Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88377629 |
LAW OFFICE ASSIGNED |
LAW OFFICE 127 |
MARK SECTION |
MARK |
ASSEMBLYBIO (see, http://uspto.report/TM/88377629/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ASSEMBLYBIO |
OWNER SECTION (current) |
NAME |
Assembly Biosciences, Inc. |
STREET |
11711 North Meridian Street, Suite 310 |
CITY |
Carmel |
STATE |
Indiana |
ZIP/POSTAL CODE |
46032 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
Assembly Biosciences, Inc. |
STREET |
11711 North Meridian Street, Suite 310 |
CITY |
Carmel |
STATE |
Indiana |
ZIP/POSTAL CODE |
46032 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Jessica L. Rothstein |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
TMadmin@goodwinlaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Jessica L. Rothstein |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
TMadmin@goodwinlaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com |
DOCKET/REFERENCE NUMBER |
ASP-612 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Biopharmaceutical products, namely, pharmaceutical preparations for treating infectious diseases, gastrointestinal dysbiosis, auto-immune
disorders, non-alcoholic steatohepatitis (NASH), immuno-oncology, metabolic disease, autism and oncologic conditions; Drug delivery systems in the form of capsules, tablets, softgels, powders, films
and liquids that facilitate delivery of a wide range of pharmaceuticals; Drug delivery systems consisting of compounds that facilitate delivery of a wide range of pharmaceuticals |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
042 |
CURRENT IDENTIFICATION |
Research and development in the bio-science and biotechnology fields; Pharmaceutical, Medical and Scientific research and development services;
Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development; Conducting clinical trials for
others; Drug discovery services |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
09/24/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
250 |
TOTAL AMOUNT |
250 |
SIGNATURE SECTION |
SIGNATURE |
/Elizabeth H. Lacy/ |
SIGNATORY'S NAME |
Elizabeth H. Lacy |
SIGNATORY'S POSITION |
General Counsel, Vice President of Legal Operations |
DATE SIGNED |
03/19/2020 |
SIGNATORY'S PHONE NUMBER |
317.975.2699 |
FILING INFORMATION |
SUBMIT DATE |
Thu Mar 19 22:00:10 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XX.XX-20
200319220010663346-883776
29-7109230d587c8d079c2a68
18d7bd9596d64ec7d3efa6f49
1e24efa51cb775be26f6-CC-0
0090981-20200317194039707
420 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ASSEMBLYBIO (see, http://uspto.report/TM/88377629/mark.png)
SERIAL NUMBER: 88377629
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Assembly Biosciences, Inc., having an address of
11711 North Meridian Street, Suite 310
Carmel, Indiana 46032
United States
Email: XXXX
Proposed: Assembly Biosciences, Inc., having an address of BB
11711 North Meridian Street, Suite 310
Carmel, Indiana 46032
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 09/24/2019.
For International Class 005:
Current identification: Biopharmaceutical products, namely, pharmaceutical preparations for treating infectious diseases, gastrointestinal dysbiosis, auto-immune disorders, non-alcoholic
steatohepatitis (NASH), immuno-oncology, metabolic disease, autism and oncologic conditions; Drug delivery systems in the form of capsules, tablets, softgels, powders, films and liquids that
facilitate delivery of a wide range of pharmaceuticals; Drug delivery systems consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 042:
Current identification: Research and development in the bio-science and biotechnology fields; Pharmaceutical, Medical and Scientific research and development services; Pharmaceutical products
development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development; Conducting clinical trials for others; Drug discovery
services
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
Correspondence Information (current):
Jessica L. Rothstein
PRIMARY EMAIL FOR CORRESPONDENCE: TMadmin@goodwinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com
Correspondence Information (proposed):
Jessica L. Rothstein
PRIMARY EMAIL FOR CORRESPONDENCE: TMadmin@goodwinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Elizabeth H. Lacy/ Date Signed: 03/19/2020
Signatory's Name: Elizabeth H. Lacy
Signatory's Position: General Counsel, Vice President of Legal Operations
Signatory's Phone: 317.975.2699
RAM Sale Number: 88377629
RAM Accounting Date: 03/19/2020
Serial Number: 88377629
Internet Transmission Date: Thu Mar 19 22:00:10 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XX-20200319220010663
346-88377629-7109230d587c8d079c2a6818d7b
d9596d64ec7d3efa6f491e24efa51cb775be26f6
-CC-00090981-20200317194039707420